Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients

BACKGROUND: For stage IV lung cancer patients receiving add-on Viscum album L. (VA) treatment an improved overall survival was detected. Information regarding cost-effectiveness (CE) for comparisons between chemotherapy (CTx) and CTx plus additive VA in stage IV lung cancer treatment is limited. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Thronicke, Anja, Reinhold, Thomas, von Trott, Philipp, Grah, Christian, Matthes, Burkhard, Matthes, Harald, Schad, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384610/
https://www.ncbi.nlm.nih.gov/pubmed/32716969
http://dx.doi.org/10.1371/journal.pone.0236426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384610/
https://www.ncbi.nlm.nih.gov/pubmed/32716969
http://dx.doi.org/10.1371/journal.pone.0236426

Ejemplares similares